Cardiovascular rehabilitation in patients after TAVI Circulatory System
Conditions
Interventions
Initially, the intervention will include a thorough medical examination, all relevant laboratory and diagnostic tests will be recorded, as well as pathological psychosocial factors and disorders.
Sponsors
University of West Attica
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Men and women aged 60-85 years 2. Will have undergone TAVI within a period of time 6 months before starting the cardiovascular rehabilitation program 3. Functional class of heart failure I to III, according to the functional classification of the New York Heart Association (NYHA) 4. Patients will be under medication and should have an ejection fraction (EF) =40% 5. Willing to be assigned to the study
Exclusion criteria
Exclusion criteria: 1. Patients with severe-grade coronary artery disease 2. Genetic and non-genetic diseases that cause systolic or diastolic dysfunction 3. History of thromboembolic and vascular events diseases 4. Patients with an individual history of syncope fainting episodes and dangerous arrhythmias 5. Autoimmune patients or endocrinological diseases 6. Respiratory ailments 7. Neoplastic, hepatic, nephrological and infectious disease 8. Patients with disorders affecting the ability to exercise
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measured at the initial visit and at the end of the study protocol: 1. Functional capacity will be measured using ergospirometric indicators as peak oxygen uptake (VO2peak), respiratory equivalent slope for carbon dioxide (VE/VCO2) 2. Survival rate will be assessed with the heart rate recovery index (HRR) 3. The effects of cardiac symptoms will be assessed with the SF-36 quality of life scale | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Countries
Greece
Contacts
Public ContactMaria Petridou
Outcome results
None listed